The development of resistance to cisplatin (CDDP) in bladder cancer presents a notable
obstacle, with indications pointing to the substantial role of circular RNAs (circRNAs) in this …

Background Cisplatin (CDDP)-based chemotherapy is a standard first-line treatment for
metastatic bladder cancer (BCa) patients, and chemoresistance remains a major challenge …

Purpose: Recent studies showed circular RNA (circRNA) played important regulatory roles
in tumors, including genesis of chemotherapy resistance. In this study, the role of circHIPK3 …

Background Cisplatin (CDDP) has become a standard-of-care treatment for muscle-invasive
bladder cancer (MIBC), while chemoresistance remains a major challenge. Accumulating …

Background Cisplatin (CDDP) is the first-line chemotherapeutic strategy to treat patients with
ovarian cancer (OC). The development of CDDP resistance remains an unsurmountable …

Cisplatin is a common chemotherapeutic drug that has been used to treat of numerous
tumors, including testicular, lung, bladder, ovarian, liver and head and neck cancers …

Circular RNAs play an important role in regulating cisplatin (CDDP) resistance in gastric
cancer (GC). The aim of this study was to examine the role and downstream regulation …

Cisplatin (CDDP) is commonly used for gastric cancer (GC) chemotherapy. However, after
several CDDP‐based treatment cycles, patients always acquire chemotherapy resistance …

Introduction Circular RNAs (circRNAs) are non-coding RNAs that have the structure of a
covalently closed loop. Increasing data have proven that circRNAs can influence the …

Emerging numbers of endogenous circular RNAs (circRNAs) have gained much attention to
serve as essential regulators in the carcinogenesis of human cancers. Unfortunately, the …